Product References
SEMG1/2 augment energy metabolism of tumor cells.
Cell death & disease
Shuvalov O,Kizenko A,Petukhov A,Fedorova O,Daks A,Bottrill A,Snezhkina AV,Kudryavtseva AV,Barlev N
PA5-30168 was used in Western Blotting to demonstrate that SEMG1 and SEMG2 are frequently expressed in lung cancer clinical samples and cancer cell lines of different origins and are negatively associated with the survival rate of cancer patients.
Fri Dec 11 00:00:00 EST 2020
SEMG1/2 augment energy metabolism of tumor cells.
Cell death & disease
Shuvalov O,Kizenko A,Petukhov A,Fedorova O,Daks A,Bottrill A,Snezhkina AV,Kudryavtseva AV,Barlev N
PA5-30168 was used in Western Blotting to demonstrate that SEMG1 and SEMG2 are frequently expressed in lung cancer clinical samples and cancer cell lines of different origins and are negatively associated with the survival rate of cancer patients.
Fri Dec 11 00:00:00 EST 2020
Cancer-testis antigens, semenogelins 1 and 2, exhibit different anti-proliferative effects on human lung adenocarcinoma cells.
Cell death discovery
Shuvalov O,Kizenko A,Petukhov A,Aksenov N,Fedorova O,Vorobev M,Daks A,Barlev N
PA5-30168 was used in Western Blotting to show SEMGs may arguably play a positive role in tumorigenesis by sensitising NSCLCs to genotoxic therapy.
Wed Oct 28 00:00:00 EDT 2020
Cancer-testis antigens, semenogelins 1 and 2, exhibit different anti-proliferative effects on human lung adenocarcinoma cells.
Cell death discovery
Shuvalov O,Kizenko A,Petukhov A,Aksenov N,Fedorova O,Vorobev M,Daks A,Barlev N
PA5-30168 was used in Western Blotting to show SEMGs may arguably play a positive role in tumorigenesis by sensitising NSCLCs to genotoxic therapy.
Wed Oct 28 00:00:00 EDT 2020
Cancer-testis antigens, semenogelins 1 and 2, exhibit different anti-proliferative effects on human lung adenocarcinoma cells.
Cell death discovery
Shuvalov O,Kizenko A,Petukhov A,Aksenov N,Fedorova O,Vorobev M,Daks A,Barlev N
PA5-30168 was used in Western Blotting to show SEMGs may arguably play a positive role in tumorigenesis by sensitising NSCLCs to genotoxic therapy.
Wed Oct 28 00:00:00 EDT 2020